Genky DrugStares Co.,Ltd., July-September (1Q) Ordinary Profit Increases by 10%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Mon Oct 28, 2024 3:00 pm JST Earnings

9267 Genky DrugStares Co.,Ltd. 【J-GAAP】

Earnings Report

Genky DrugStares Co.,Ltd. <9267> [TSE-P] announced its financial results after the market closed on October 28th (15:00). The consolidated ordinary profit for the first quarter of the fiscal year ending June 2025 (July to September) increased by 10.1% from the same period last year, reaching 2.3 billion yen. However, The progress rate against the 5.11 billion yen plan for the six months ending December (first half) was 45.0%, also falling below the five-year average of 52.3%.

In the most recent three-month period, from July to September (1Q), the operating profit margin remained almost flat, changing from 4.3% in the same period last year to 4.5%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jul - Sep, 2022	42,613	1,584	1,688	1,102	36.3	47.4	Oct 24, 2022	J-GAAP
Jul - Sep, 2023	46,871	2,015	2,089	1,444	47.6	46.5	Oct 30, 2023	J-GAAP
Jul - Sep, 2024	50,050	2,272	2,300	1,584	52.1	45.0	Oct 28, 2024	J-GAAP
YoY	+6.8%	+12.8%	+10.1%	+9.7%	+9.6%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2023	91,967	4,387	4,495	3,087	101.7	6.25	Jan 29, 2024	J-GAAP
Jul - Dec, 2024 Guidance	100,000	5,000	5,110	3,500	115.2	6.50	Jul 29, 2024	J-GAAP
YoY	+8.7%	+14.0%	+13.7%	+13.4%	+13.3%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jun, 2023	169,059	6,709	7,079	4,764	156.9	12.50	Jul 24, 2023	J-GAAP
Jun, 2024	184,860	9,015	9,268	6,324	208.2	12.75	Jul 29, 2024	J-GAAP
Jun, 2025 Guidance	202,000	10,000	10,220	7,000	230.3	13	Jul 29, 2024	J-GAAP
YoY	+9.3%	+10.9%	+10.3%	+10.7%	+10.6%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	46,871	2,015	2,089	1,444	47.6	4.3	Oct 30, 2023	J-GAAP
Oct - Dec, 2023	45,096	2,372	2,406	1,643	54.1	5.3	Jan 29, 2024	J-GAAP
Jan - Mar, 2024	44,620	2,107	2,193	1,369	45.1	4.7	Apr 25, 2024	J-GAAP
Apr - Jun, 2024	48,273	2,521	2,580	1,868	61.5	5.2	Jul 29, 2024	J-GAAP
Jul - Sep, 2024	50,050	2,272	2,300	1,584	52.1	4.5	Oct 28, 2024	J-GAAP
YoY	+6.8%	+12.8%	+10.1%	+9.7%	+9.6%